Qiagen today announced organizational changes that include the creation of two new business areas, Molecular Diagnostics and Life Sciences, which will become operational on July 1.
CEO Peer Schatz announced the changes during a conference call recapping the company's first-quarter 2012 financial results.
As part of the changes, new executive committee member Helge Lubenow has been appointed senior vice president of the Molecular Diagnostics unit. Lubenow has been with Qiagen since 1997 and is currently vice president of molecular diagnostics marketing.
Dietrich Hauffe, also a new executive committee member, has been appointed senior vice president of the Life Sciences unit. He is currently VP of life sciences marketing.
Joachim Schorr, managing director and senior VP of global research and development, is leaving Qiagen, but will provide consulting services for the firm, the company said. He will depart during the second quarter.